Search
for
Sort by
Research 91–120 of 287
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Clinical Manifestation of Alopecia Areata After COVID-19 Infection or Vaccination
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Pharmacological Treatment of Alopecia
- Vitamin D, Lipid Metabolism and Prostate Cancer
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Novel drugs of United States Food and Drug Administration approved in 2024
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- All Subcomponents of the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) are Relevant to Identify and Detect Changes in Skin Activity
- The genetic basis of dermatophytosis skin infection susceptibility
- Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Farmácia Avenida - Guimarães e nos Serviços Farmacêuticos da Unidade Local de Saúde do Alto Ave, EPE - Guimarães
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Bioavailability File: Bicalutamide
- Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program
- Worldwide Clinical and Real-World Exposure to Baricitinib
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- Relatório de Estágio realizado na Farmácia Santiago
- Bacteria induce skin regeneration via IL-1β signaling
- The nocebo effect: A clinicians guide
- Improved hair restoration method for burns
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Microneedling as a successful treatment for alopecia X in two Pomeranian siblings
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis